Olema Pharmaceuticals, Inc. (OLMA)
10.27
-0.52
(-4.82%)
USD |
NASDAQ |
Aug 28, 16:00
10.27
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Total Liabilities (Quarterly) : 56.01M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 56.01M |
| March 31, 2026 | 50.17M |
| December 31, 2025 | 198.76M |
| September 30, 2025 | 44.96M |
| June 30, 2025 | 36.77M |
| March 31, 2025 | 26.19M |
| December 31, 2024 | 42.02M |
| September 30, 2024 | 31.26M |
| June 30, 2024 | 27.39M |
| March 31, 2024 | 27.38M |
| December 31, 2023 | 23.05M |
| September 30, 2023 | 17.66M |
| Date | Value |
|---|---|
| June 30, 2023 | 16.04M |
| March 31, 2023 | 20.79M |
| December 31, 2022 | 18.10M |
| September 30, 2022 | 14.30M |
| June 30, 2022 | 14.32M |
| March 31, 2022 | 12.33M |
| December 31, 2021 | 11.38M |
| September 30, 2021 | 8.901M |
| June 30, 2021 | 8.146M |
| March 31, 2021 | 5.277M |
| December 31, 2020 | 4.585M |
| September 30, 2020 | 5.273M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 486.58M |
| Shareholders Equity (Quarterly) | 430.56M |
| Debt to Equity Ratio | 0.0085 |
| Current Ratio | 8.863 |
| Net Debt Paydown Yield | -0.05% |